INTRODUCTION 1
There are sex differences in the risk of cardiovascular disease in people with diabetes. Compared 2 to men, women with diabetes have a 40% higher risk of incident coronary heart disease 1 and 3 27% higher risk of stroke. 2 However, sex differences in outcomes in diabetic patients following 4 an incident event are unclear, with conflicting findings in previous studies. 3, 4 Sex differences 5 have been demonstrated for myocardial infarction (MI) 5, 6 and other cardiovascular disease, 7 but 6 data on sex differences in outcomes among people with diabetes after incident stroke are less 7 consistent. Relatively small studies have reported higher in-hospital mortality 8 and long-term 8 mortality 9 for diabetic females, but others have shown no association of sex and outcomes 10, 11 9
Furthermore, prior studies mostly examined mortality and did not measure readmission rates. 10
Studies to date have not adequately assessed for socioeconomic status and medication usage, 11 which may confound the relationship between sex and outcomes. There is a lack of reliable 12 population-based data on the effect of sex on mortality and readmissions among diabetic patients 13 following an incident stroke. 14 The objective of this analysis was to examine differences in cardiovascular events and 15 mortality by sex and age among those with diabetes after ischemic stroke in Ontario. We 16 hypothesized that women had higher mortality compared to men and that the readmission risk for 17 cardiovascular events differed by sex. 18 
19

METHODS
20
We conducted a retrospective analysis of a population-based sample using linked administrative 21 databases in Ontario, Canada's most populous province. Because of government-funded health 22 insurance for all permanent residents of Ontario, data were available on the entire population. 23
Longitudinal follow-up 22
Outcomes were: death, any-cause readmission, stroke/TIA readmission, MI readmission, stroke 1 or MI readmission, and a composite of death or any-cause readmission. To create these 2 outcomes, hospital readmissions for the following were assessed: recurrent stroke/TIA (ICD-10 
Statistical analysis 8
Baseline characteristics were reported in the overall sample and stratified by sex. We calculated 9
proportions for categorical variables and means and medians for continuous variables. Incidence 10 was calculated as the incidence of each outcome per 100 person-years (with 95% confidence 11 intervals), reported by age and sex subgroups. Two significance tests were performed using a 12 and there were higher rates of death among higher age groups ( Table 2 ). Kaplan-Meier curves 15 showed lower survival probability for females compared to males (p<0.0001) ( Figure 1A There were 17,406 any-cause readmissions during follow-up, of which 3,794 were for 21 stroke and 2,512 for MI. The unadjusted incidence rate of readmission for any cause or for stroke 22 was similar by sex (Table 2 ). There was higher unadjusted incidence among males for 23 readmission due to MI (1.99, 95% CI 1.89-2.10 vs. 1.58, 95% CI 1.49-1.68 among females). 1
There was a pattern of increased incidence of death and lower incidence of readmissions for 2 stroke, MI, and stroke or MI among successively higher age categories, probably reflecting the 3 competing risk of death for stroke and MI (Table 2 ). Kaplan-Meier curves showed a similar 4 survival probability for males and females of any readmission ( Figure 1B ) and stroke 5 readmission (Figure 2A ), but a higher risk of MI readmission among males ( Figure 2B ). 6
In multivariable competing risk models, females had a lower risk of readmission for any 7 event (0.96, 95% CI 0.93-0.99, Table 3 ). There was no sex difference in risk of readmission for 8 stroke, but females had a lower risk of MI readmission compared to males (0.88, 95% CI 0.81-9 0.95). Among those age ≥65 years with and without adjustment for medication usage, risk of 10 readmission for any event remained lower in females but risk of MI readmission was no longer 11 different by sex. 12 
13
DISCUSSION 14
In this population-based, retrospective study using administrative linkage with full population 15 coverage for the province of Ontario, we found that women with diabetes, compared to men, had 16 higher unadjusted mortality and risk of readmission for any cause or death following an incident 17 stroke but lower risk of readmission for MI. Unadjusted readmission rates for any cause and for 18 stroke were similar by sex. Diabetic female patients with incident stroke were older and from a 19 lower socioeconomic status. They were more likely to have hypertension and atrial fibrillation 20 but less likely to have prior MI, CAD, or PVD. They were also less likely to be taking diabetic 21
and statin medications at baseline and had a longer average length of hospital stay during the 22 incident stroke, suggesting either differences in disease severity or disparities in optimal 23 treatment by sex. These differences likely accounted for the unadjusted mortality difference seen 1 by sex, because in adjusted models females had lower risk of death and lower risk of any-cause 2 readmissions compared to males, although the increased risk of MI among males persisted after 3 adjustment. Readmission rates for stroke remained similar between males and females in 4 adjusted models. Also, as expected, there was a higher risk of mortality and lower risk of 5 readmission with increasing age, likely due to the competing risk of death. 6
The impact of traditional cardiovascular risk factors varies by sex, especially for smoking 7 (which carries a 25% greater risk for coronary heart disease among women than men 17, 18 ) and 8 diabetes. 1, 2, 17, 18 In addition to traditional risk factors, there are risk factors specific to women, 9
including gestational hypertension and pre-eclampsia, gestational diabetes, and placental 10 disorders such as intrauterine growth restriction and stillbirth. 17, [19] [20] [21] Polycystic ovarian 11 syndrome, the most common female endocrine disorder, results in insulin resistance and 12 development of metabolic syndrome. 22 Oral contraceptive pills, used by 82% of sexually ever-13 active women, are associated with elevated risk of venous thrombosis, MI and ischemic stroke 14 from a presumed pro-coagulant effect. 18 Systemic autoimmune collagen vascular diseases, such 15 as systemic lupus erythematous and rheumatoid arthritis, are more common in females and lead 16 to accelerated atherosclerosis and progression to heart disease. 20, 21 Depression is twice as 17 common in women and associated with a 70% risk for heart disease; it can lead to non-adherence 18 with diet, medications, and follow-up. 20 Social support and self-reported quality of life have also been reported to be lower in 20 diabetic women. 23, 24 Prior studies show that women have lower socioeconomic status and lower 21 access to preventative measures and treatments for diabetes. 7, 25 There are also treatment 22 disparities -women are less likely to be prescribed medications for modifiable risk factors and, 23 even when undergoing treatment, they are treated less effectively. 20, 22, 26, 27 Our findings also 1 reflect this female socioeconomic disadvantage as well as lower medication usage, despite 2 universal health coverage. 3
Prior studies of sex differences in outcomes among diabetic stroke patients have been in 4 smaller samples, focused on mortality, and with limited control of socioeconomic status and 5 medication usage. [8] [9] [10] In a Spanish prospective single center stroke registry of 561 diabetic stroke 6 patients, there was higher mortality among women but similar stroke recurrence rates by sex. 8 
7
Elevated female mortality and similar stroke recurrence rates by sex were also reported in a 8 single-center Chinese study of 2360 diabetic stroke patients. 10 In a Swedish population-based 9 study involving 2549 diabetic stroke patients under age 75 years, there was also higher mortality 10 noted in females; however readmissions were not assessed. 9 
11
Our study included over 25,000 diabetic stroke patients and provides reliable evidence 12 that women have higher mortality after stroke. We demonstrated that this difference is not 13 present after adequate adjustment, and women actually have a lower age-adjusted risk for 14 mortality. This finding is in agreement with a recent meta-analysis using 16,957 pooled 15 individual participant data from 13 population-based stroke incidence studies from Europe, 16 Australia, South America, and the Caribbean; it reported a lower crude survival rate in women at 17 1 and 5 years, which was reversed after adjustment. 28 The 5-year pooled estimates had 18 significant heterogeneity because few studies had follow-up beyond 1 year and there was 19 missing data across studies, particularly on stroke risk factors such as diabetes (only 5 out of 13 20 studies reported diabetes status, n=667). Our current report consist of more patients than all 13 21 studies combined and provides confirmation that female sex, by itself, is not responsible for 22 increased mortality after stroke in those with diabetes. Beyond mortality outcomes, we also 23 demonstrate that there is no sex difference in stroke readmission risk, but males are at higher risk 1 of readmission for MI. To our knowledge, there have been no prior studies among diabetic 2 patients with incident stroke reporting the effect of sex and MI vs stroke readmissions. 3 We found that men had higher risk of MI readmission, suggesting a possible sex-specific 4 sensitivity to different diabetes-related complications that has been previously demonstrated. 27 
5
Men, compared to women, have been reported to have higher coronary atheroma burden, more 6 diffuse endothelial dysfunction, more severe structural abnormalities in the epicardial coronary 7 arteries, and more vulnerable plaques. 29 Young women are at lower risk of cardiovascular death, 8 MI, and stroke compared to males, presumably from the cardiovascular protective effects of 9 estrogen. 20, 29, 30 However, the risk profile reverses after menopause with a 10-fold rise in 10 cardiovascular disease in women compared to a 4.5-fold rise in men of similar age. 20, 29, 30 The 11 protective effects of estrogen likely explains the disappearance of the elevated MI readmission 12 risk when the sample is restricted to those above age 65, with or without adjustment for 13 medication usage. Interestingly, this same protective effect was not seen for stroke readmission 14 in analyses of the unadjusted, adjusted, and age >65 subgroup models. This suggests that 15 diabetes in pre-menopausal women may blunt the protective effects of estrogen to varying 16 degrees which may be organ specific. 17, 20, 30, 31 This study attempts to overcome several limitations of prior studies in the area of sex 18 differences after ischemic stroke. Due to universal health coverage in Ontario, the sample is 19 unprecedented in that it includes all adults with diabetes and index ischemic stroke in a large 20 Canadian province, not just patients from a single center or a population sample. Hence, this 21 results in extensive population coverage over a long follow-up period with limited selection bias. 22
Lack of power to detect sex differences is not a concern. Also, due to the unique linking among 23 different databases, adjustment for the important confounders of socioeconomic status and 1 medication use was possible. 2
There are limitations associated with the usage of administrative and claims-based data, 3 which may be prone to misclassification and inaccuracy. For example, sample selection using 4 ICD code I64, "stroke, not specified as hemorrhagic or infarct", could possibly capture stroke-5 types other than ischemic stroke. However, the sensitivity and specificity of diagnosis based on 6 ICD-10-based codes has been shown to be excellent. We only have data on events that resulted 7 in readmission; therefore some events such as TIA may be missed if patients were not admitted 8 to the hospital. Data on stroke characteristics, such as subtype, severity, location, size, and 9 discharge handicap were not available. Similarly, data was available on duration of diabetes but 10 not on severity of diabetes as assessed by hemoglobin A1c levels. We were able to control for 11 diabetic, statin and anti-hypertensive medication but could not assess for aspirin usage as it is 12 available over the counter and therefore could not be reliably controlled. Aspirin's role in 13 preventing cardiovascular events in diabetic women is uncertain. 22 There is insufficient evidence 14 that aspirin has a sex-specific cardiovascular impact, and further study is indicated. 15 Cardiovascular prevention may need to be tailored according to sex, and some studies have 16 suggested differential effectiveness of interventions by sex. 32, 33 A structured personalized 17 approach may be more effective for women compared to men, but more research is needed. 23 
18
In summary, we demonstrated that diabetic female patients have higher mortality after 19 incident stroke, but female sex was not an independent risk factor. Contrary to previous studies, 20 female sex was associated with lower mortality after adjustment for vascular risk factors, 21 demographics, socioeconomic status, and medication usage. 
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